Elimination af hepatitis C-virus i Danmark

Anna Døssing; Birgitte Thorup Røge; Lone Galmstrup Madsen; Alex Lund Laursen; Jesper Bach Hansen; Jens Bukh; Nina Weis

Elimination af hepatitis C-virus i Danmark

Anna Døssing, Birgitte Thorup Røge, Lone Galmstrup Madsen, Alex Lund Laursen, Jesper Bach Hansen, Jens Bukh, Nina Weis

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abstract

In Denmark, about 50% of patients with chronic hepatitis C virus (HCV) infection are undiagnosed. Since 2014, therapy containing direct-acting antivirals (DAA) has proven efficient and is available to all patients, who have a chronic HCV infection and a Danish personal identification number. The World Health Organization has a goal of elimination of viral hepatitis in 2030. Elimination of HCV in Denmark should focus on reducing HCV transmission, incidence and prevalence, combined with treatment with DAA of all infected patients. Micro-elimination strategies may play a major role, but a national strategy is lacking.

Bidragets oversatte titel	Elimination of hepatitis C virus in Denmark
Originalsprog	Dansk
Artikelnummer	V08190481
Tidsskrift	Ugeskrift for Laeger
Vol/bind	182
Udgave nummer	19
Sider (fra-til)	1762-1765
ISSN	0041-5782
Status	Udgivet - 24 feb. 2020

Adgang til dokumentet

https://ugeskriftet.dk/videnskab/elimination-af-hepatitis-c-virus-i-danmark

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

@article{8c5b5e35a4734445820fa3885a87c35d,

title = "Elimination af hepatitis C-virus i Danmark",

abstract = "In Denmark, about 50% of patients with chronic hepatitis C virus (HCV) infection are undiagnosed. Since 2014, therapy containing direct-acting antivirals (DAA) has proven efficient and is available to all patients, who have a chronic HCV infection and a Danish personal identification number. The World Health Organization has a goal of elimination of viral hepatitis in 2030. Elimination of HCV in Denmark should focus on reducing HCV transmission, incidence and prevalence, combined with treatment with DAA of all infected patients. Micro-elimination strategies may play a major role, but a national strategy is lacking.",

author = "Anna D{\o}ssing and R{\o}ge, {Birgitte Thorup} and Madsen, {Lone Galmstrup} and Laursen, {Alex Lund} and Hansen, {Jesper Bach} and Jens Bukh and Nina Weis",

year = "2020",

month = feb,

day = "24",

language = "Dansk",

volume = "182",

pages = "1762--1765",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "19",

}

TY - JOUR

T1 - Elimination af hepatitis C-virus i Danmark

AU - Døssing, Anna

AU - Røge, Birgitte Thorup

AU - Madsen, Lone Galmstrup

AU - Laursen, Alex Lund

AU - Hansen, Jesper Bach

AU - Bukh, Jens

AU - Weis, Nina

PY - 2020/2/24

Y1 - 2020/2/24

N2 - In Denmark, about 50% of patients with chronic hepatitis C virus (HCV) infection are undiagnosed. Since 2014, therapy containing direct-acting antivirals (DAA) has proven efficient and is available to all patients, who have a chronic HCV infection and a Danish personal identification number. The World Health Organization has a goal of elimination of viral hepatitis in 2030. Elimination of HCV in Denmark should focus on reducing HCV transmission, incidence and prevalence, combined with treatment with DAA of all infected patients. Micro-elimination strategies may play a major role, but a national strategy is lacking.

AB - In Denmark, about 50% of patients with chronic hepatitis C virus (HCV) infection are undiagnosed. Since 2014, therapy containing direct-acting antivirals (DAA) has proven efficient and is available to all patients, who have a chronic HCV infection and a Danish personal identification number. The World Health Organization has a goal of elimination of viral hepatitis in 2030. Elimination of HCV in Denmark should focus on reducing HCV transmission, incidence and prevalence, combined with treatment with DAA of all infected patients. Micro-elimination strategies may play a major role, but a national strategy is lacking.

M3 - Tidsskriftartikel

C2 - 32138816

SN - 0041-5782

VL - 182

SP - 1762

EP - 1765

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 19

M1 - V08190481

ER -

Elimination af hepatitis C-virus i Danmark

Abstract

Adgang til dokumentet

AUB Link

Fingeraftryk

Citationsformater